American International Group’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-241
Closed -$160K 3092
2023
Q1
$160K Buy
241
+5
+2% +$4.44K ﹤0.01% 2234
2022
Q4
$207K Buy
236
+5
+2% +$6.29K ﹤0.01% 2114
2022
Q3
$254K Buy
231
+3
+1% +$3.96K ﹤0.01% 2020
2022
Q2
$189K Sell
228
-13
-5% -$13.4K ﹤0.01% 2214
2022
Q1
$374K Sell
241
-17
-7% -$22.9K ﹤0.01% 1887
2021
Q4
$464K Buy
258
+1
+0.4% +$2.67K ﹤0.01% 1866
2021
Q3
$847K Sell
257
-6
-2% -$21K ﹤0.01% 1526
2021
Q2
$1.16K Buy
+263
New +$1.04M ﹤0.01% 1432

Other funds holding BNGO

American International Group's BNGO Position: Q2 2023 in Review

American International Group sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 241 shares — an estimated $160K sold.

American International Group first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $847K in Q3 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • American International Group reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 241 Bionano Genomics shares in Q2 2023, an estimated $160K.
  • American International Group first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • American International Group's Bionano Genomics position peaked at $847K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.